Literature DB >> 34213406

Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan.

Tomohiro Ishimaru1, Makoto Okawara1, Hajime Ando2, Ayako Hino3, Tomohisa Nagata4, Seiichiro Tateishi5, Mayumi Tsuji6, Shinya Matsuda7, Yoshihisa Fujino1.   

Abstract

Many factors are related to vaccination intentions. However, gender differences in the determinants of intention to get the coronavirus disease 2019 (COVID-19) vaccine have not been fully investigated. This study examined gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan. We conducted a cross-sectional study of Japanese citizens aged 20-65 years using an online self-administered questionnaire in December 2020. Logistic regression analysis was performed. Among 27,036 participants (13,814 men and 13,222 women), the percentage who were willing to get the COVID-19 vaccine was lower among women than among men (33.0% vs. 41.8%). Age and education level showed a gender gap regarding the association with willingness to get the COVID-19 vaccine: men who were older or had a higher level of education were more willing to get the vaccine, whereas women aged 30-49 years and those with a higher level of education showed a relatively low willingness to get the vaccine. For both men and women, marriage, higher annual household income, underlying disease, current smoking, vaccination for influenza during the current season, and fear of COVID-19 transmission were linked to a higher likelihood of being willing to get the COVID-19 vaccine. These findings give important insight into identifying target groups in need of intervention regarding COVID-19 vaccination, especially among women. Providing education about COVID-19 and influenza vaccination in the workplace may be an effective strategy to increase COVID-19 vaccine uptake.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; employees; infection; occupational health; vaccine; working age

Mesh:

Substances:

Year:  2021        PMID: 34213406      PMCID: PMC8827630          DOI: 10.1080/21645515.2021.1947098

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  34 in total

1.  Covid-19: Japan declares second state of emergency as Asia struggles with virus surge.

Authors:  Mun-Keat Looi
Journal:  BMJ       Date:  2021-01-15

2.  Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-12-11

3.  Developing Covid-19 Vaccines at Pandemic Speed.

Authors:  Nicole Lurie; Melanie Saville; Richard Hatchett; Jane Halton
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

4.  Current knowledge of and attitudes toward human papillomavirus-related disease prevention among Japanese: A large-scale questionnaire study.

Authors:  Yukio Suzuki; Akiko Sukegawa; Aya Nishikawa; Kazumi Kubota; Yoko Motoki; Mikiko Asai-Sato; Yutaka Ueda; Masayuki Sekine; Takayuki Enomoto; Fumiki Hirahara; Takeharu Yamanaka; Etsuko Miyagi
Journal:  J Obstet Gynaecol Res       Date:  2019-02-05       Impact factor: 1.730

5.  Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo.

Authors:  Siyan Yi; Daisuke Nonaka; Marino Nomoto; Jun Kobayashi; Tetsuya Mizoue
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

6.  Willingness to vaccinate against COVID-19 in Australia.

Authors:  Rachael H Dodd; Erin Cvejic; Carissa Bonner; Kristen Pickles; Kirsten J McCaffery
Journal:  Lancet Infect Dis       Date:  2020-06-30       Impact factor: 25.071

7.  Willingness to Receive COVID-19 Vaccination in Japan.

Authors:  Takeshi Yoda; Hironobu Katsuyama
Journal:  Vaccines (Basel)       Date:  2021-01-14

8.  Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).

Authors:  Ludger Klimek; Natalija Novak; Eckard Hamelmann; Thomas Werfel; Martin Wagenmann; Christian Taube; Andrea Bauer; Hans Merk; Uta Rabe; Kirsten Jung; Wolfgang Schlenter; Johannes Ring; Adam Chaker; Wolfgang Wehrmann; Sven Becker; Norbert Mülleneisen; Katja Nemat; Wolfgang Czech; Holger Wrede; Randolf Brehler; Thomas Fuchs; Thilo Jakob; Tobias Ankermann; Sebastian M Schmidt; Michael Gerstlauer; Christian Vogelberg; Thomas Zuberbier; Karin Hartmann; Margitta Worm
Journal:  Allergo J Int       Date:  2021-02-24

9.  Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

Authors:  Paul L Reiter; Michael L Pennell; Mira L Katz
Journal:  Vaccine       Date:  2020-08-20       Impact factor: 3.641

10.  Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study.

Authors:  Alexandre de Figueiredo; Clarissa Simas; Emilie Karafillakis; Pauline Paterson; Heidi J Larson
Journal:  Lancet       Date:  2020-09-10       Impact factor: 202.731

View more
  17 in total

1.  Public Opinion and Sentiment Before and at the Beginning of COVID-19 Vaccinations in Japan: Twitter Analysis.

Authors:  Qian Niu; Junyu Liu; Masaya Kato; Yuki Shinohara; Natsuki Matsumura; Tomoki Aoyama; Momoko Nagai-Tanima
Journal:  JMIR Infodemiology       Date:  2022-05-09

2.  "When did you decide to receive the Covid-19 vaccine?" Survey in a high-volume vaccination center.

Authors:  Marion Le Maréchal; Amina Batel; Stéphanie Bouvier; Hajer Mahdhaoui; Morgane Margotton; Jean-Philippe Vittoz; Etienne Brudieu; Christine Chevallier; Pierrick Bedouch; Saber Touati; Olivier Epaulard
Journal:  Hum Vaccin Immunother       Date:  2022-01-18       Impact factor: 3.452

3.  Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review.

Authors:  Fidelia Cascini; Ana Pantovic; Yazan Al-Ajlouni; Giovanna Failla; Walter Ricciardi
Journal:  EClinicalMedicine       Date:  2021-09-02

4.  Effect of a Concise Educational Program on COVID-19 Vaccination Attitudes.

Authors:  Arielle Kaim; Maya Siman-Tov; Eli Jaffe; Bruria Adini
Journal:  Front Public Health       Date:  2021-11-30

5.  Intentions Regarding COVID-19 Vaccination in Females Aged 15-49 Years.

Authors:  Shihoko Kajiwara; Naomi Akiyama; Michio Ohta
Journal:  Vaccines (Basel)       Date:  2022-02-20

6.  Association between willingness to receive the COVID-19 vaccine and sources of health information among Japanese workers: a cohort study.

Authors:  Ko Hiraoka; Tomohisa Nagata; Takahiro Mori; Hajime Ando; Ayako Hino; Seiichiro Tateishi; Mayumi Tsuji; Shinya Matsuda; Yoshihisa Fujino
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

7.  Analysis of People's Attitude Toward COVID-19 Vaccine and Its Information Sources in Thailand.

Authors:  Takeshi Yoda; Benjamas Suksatit; Masaaki Tokuda; Hironobu Katsuyama
Journal:  Cureus       Date:  2022-02-14

8.  Association between work-related changes caused by the COVID-19 pandemic and severe psychological distress among Japanese workers.

Authors:  Naoki Shiota; Tomohiro Ishimaru; Makoto Okawara; Yoshihisa Fujino; Takahiro Tabuchi
Journal:  Ind Health       Date:  2021-10-15       Impact factor: 2.707

9.  COVID-19 vaccine acceptability among healthcare workers in Ethiopia: Do we practice what we preach?

Authors:  Daniel Yilma; Rezika Mohammed; Seid Getahun Abdela; Wendemagegn Enbiale; Fasil Seifu; Myrthe Pareyn; Laurens Liesenborghs; Johan van Griensven; Saskia van Henten
Journal:  Trop Med Int Health       Date:  2022-03-20       Impact factor: 3.918

10.  Analysis of social combinations of COVID-19 vaccination: Evidence from a conjoint analysis.

Authors:  Hanako Ohmura
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.